We are live on
!
Find out more
Hotchkis & Wiley Capital Management Portfolio holdings
AUM
$32.4B
1-Year Est. Return
17.21%
This Fund
S&P 500
This Quarter
Est. Return
+3.4%
1 Year Est. Return
+17.21%
3 Year Est. Return
+50.62%
5 Year Est. Return
+65.05%
10 Year Est. Return
+239.32%
AUM
$28.3B
AUM Growth
+$1.34B
(+5%)
Cap. Flow
+$417M
Cap. Flow
% of AUM
1.48%
Top 10 Holdings %
Top 10 Hldgs %
26.29%
Holding
204
New
13
Increased
105
Reduced
65
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$266M |
| 2 |
Honda
HMC
|
+$206M |
| 3 |
Eli Lilly
LLY
|
+$193M |
| 4 |
Ericsson
ERIC
|
+$175M |
| 5 |
CMCSK
COMCAST CORP SPL A (NEW)
CMCSK
|
+$150M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Exelon
EXC
|
+$291M |
| 2 |
Johnson & Johnson
JNJ
|
+$253M |
| 3 |
TotalEnergies
TTE
|
+$235M |
| 4 |
NRG Energy
NRG
|
+$173M |
| 5 |
Wells Fargo
WFC
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 26.89% |
| 2 | Technology | 13.69% |
| 3 | Healthcare | 12.43% |
| 4 | Industrials | 9.84% |
| 5 | Energy | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mondelez International
MDLZ
$79.9B
| $164M | 0.58% |
4,371,981
-27,913
| -0.6% | -$1.02M |
|
52
Upbound Group
UPBD
$1.16B
| $161M | 0.57% |
5,596,926
-118,846
| -2% | -$3.36M |
|
53
Zimmer Biomet
ZBH
$18.4B
| $160M | 0.56% |
1,582,435
-64,848
| -4% | -$6.33M |
|
|
DOOR
54
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $159M | 0.56% |
2,826,334
+335,891
| +13% | +$18.3M |
|
55
Avnet
AVT
$7.92B
| $158M | 0.56% |
3,574,600
+448,100
| +14% | +$19.7M |
|
|
PHH
56
DELISTED
PHH Corporation
PHH
| $158M | 0.56% |
6,861,642
+525,317
| +8% | +$12.5M |
|
|
K
57
DELISTED
Kellanova
K
| $156M | 0.55% |
2,535,171
-55,548
| -2% | -$3.48M |
|
58
White Mountains Insurance
WTM
$5.13B
| $156M | 0.55% |
256,478
+21,097
| +9% | +$12.6M |
|
59
Kohl's
KSS
$2.19B
| $155M | 0.55% |
2,940,333
+613,333
| +26% | +$33.2M |
|
60
McDonald's
MCD
$195B
| $155M | 0.55% |
1,537,535
+28,636
| +2% | +$2.89M |
|
61
Regions Financial
RF
$26.8B
| $153M | 0.54% |
14,414,500
+3,143,300
| +28% | +$32.8M |
|
|
62
Johnson & Johnson
JNJ
$625B
| $149M | 0.53% |
1,426,614
-2,506,371
| -64% | -$253M |
|
63
Quest Diagnostics
DGX
$26.3B
| $148M | 0.52% |
2,523,400
+27,900
| +1% | +$1.63M |
|
|
ESRX
64
DELISTED
Express Scripts Holding Company
ESRX
| $133M | 0.47% |
1,918,200
+643,800
| +51% | +$45.3M |
|
|
EMBJ
65
Embraer S.A. ADS
EMBJ
$13B
| $125M | 0.44% |
3,438,516
+139,276
| +4% | +$4.92M |
|
66
Medtronic
MDT
$112B
| $123M | 0.44% |
1,932,500
-134,300
| -6% | -$8.16M |
|
67
Lear
LEA
$8.18B
| $122M | 0.43% |
1,368,014
-511,613
| -27% | -$44M |
|
|
WCG
68
DELISTED
Wellcare Health Plans, Inc.
WCG
| $117M | 0.41% |
1,571,155
+80,755
| +5% | +$5.76M |
|
69
Philip Morris
PM
$295B
| $109M | 0.39% |
1,298,397
+1,163,580
| +863% | +$100M |
|
|
LPNT
70
DELISTED
LifePoint Health, Inc.
LPNT
| $109M | 0.39% |
1,758,516
-114,084
| -6% | -$6.69M |
|
71
Goldman Sachs
GS
$303B
| $108M | 0.38% |
+642,600
| New | +$104M |
|
72
Edison International
EIX
$26.4B
| $105M | 0.37% |
1,815,292
-562,573
| -24% | -$31.5M |
|
73
Bunge Global
BG
$20.8B
| $105M | 0.37% |
1,394,136
+638,936
| +85% | +$49.4M |
|
74
CDW
CDW
$17B
| $105M | 0.37% |
3,288,264
-261,536
| -7% | -$7.67M |
|
|
75
Exelon
EXC
$47B
| $104M | 0.37% |
4,007,937
-11,419,646
| -74% | -$291M |
|
Similar funds
GAM
PPF
Hotchkis & Wiley Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, Hotchkis & Wiley Capital Management held 204 positions worth $28.3B, up 5% from $27B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Hotchkis & Wiley Capital Management's Q2 2014 filing shows 13 new, 105 increased, 65 reduced and 10 closed positions. Its largest new stake was Honda: 5,996,624 shares worth $210M. The largest sale was Exelon, an estimated $291M.
By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.
- Hotchkis & Wiley Capital Management's largest Q2 2014 buy was Honda: 5,996,624 shares worth $210M.
- Hotchkis & Wiley Capital Management added most to GSK in Q2 2014, an estimated $266M increase.
- Hotchkis & Wiley Capital Management's biggest Q2 2014 reduction was Exelon, cutting an estimated $291M.
- Hotchkis & Wiley Capital Management fully exited Aptiv in Q2 2014, selling an estimated $62.7M.
- Hotchkis & Wiley Capital Management's ten largest holdings make up 26% of its $28.3B portfolio in Q2 2014.
- Hotchkis & Wiley Capital Management opened 13 new positions and closed 10 in Q2 2014.
- Hotchkis & Wiley Capital Management's portfolio value rose 5% quarter-over-quarter to $28.3B.
Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.